Paper # 645 
Incidence, Genotype Distribution, and Prognosis of Sexually Transmitted Acute Hepatitis C in a Cohort of HIV-infected Patients
Hans-Jürgen Stellbrink*1, K Schewe1, M Vogel2, C Hoffmann3, and C Noah3
1ICH, Hamburg, Germany; 2Universitätsklinik Bonn, Germany; and 3IPM Biotech GmbH, Hamburg, Germany
Background: To assess incidence, genotype (GT)
distribution, and prognosis of sexually transmitted acute hepatitis C infection
since 2001, in a cohort of predominantly MSM.
Methods: Cases of acute hepatitis C were identified
from a cohort of 4421 HIV-infected subjects since January 2001. Rate ratios
were determined and compared, and GT distribution and clinical course with or
without pegIFN/RBV treatment was analyzed.
Results: In the study, 46 cases were identified (all
MSM). Thirty-two subjects received HAART and 14 were untreated for HIV. Incidence
rates (95%CI) per 1000 PYFU increased over time: 2001 to 2002: 0.15 (-0.14 to
0.43); 2003 to 2004: 1.31 (0.54 to 2.08); 2005 to 2006: 2.08 (1.03 to 3.13);
2007 to 2008: 2.48 (1.36 to 3.59). 20 (43%) had HCV GT 1, 1 (2%) GT 2, 9 (20%)
GT 3, and 16 (35%) GT 4. Thirty-four subjects received peg-IFN/RBV. SVR was
achieved in 20 (65% of the 31 subjects with follow-up after treatment), relapse
occurred in 3 (10%), and primary non-response was observed in 8 (26%). Currently,
3 subjects are on treatment. Ten patients (22%/46) cleared HCV spontaneously,
and 2 (4%) remain untreated with persistent infection. Re-infection occurred in
5 individuals (17%) of those who cleared acute hepatitis C infection (3 with
different genotypes, 1 with the same, 1 with pending GT). After primary
infection with GT3, one patient developed severe hepatitis upon second
re-infection with GT1; this patient cleared HCV all 3 times without therapy.
Conclusions: We observed an increase in acute, sexually
transmitted HCV infections since 2001. The high prevalence of GT 4 compared
with other case series argues for regional differences in the transmission of
HCV strains. Overall, 65% of all infected subjects achieved SVR either
spontaneously or by treatment. Re-infection appears to occur frequently,
emphasizing the need for further prevention efforts. Future studies should
investigate the contribution of acute acute hepatitis C infection to acute
hepatitis C infection transmission and possible epidemiological links between
subjects with the same genotype.
|